<DOC>
	<DOCNO>NCT00796809</DOCNO>
	<brief_summary>The goal project study risk coccidioidomycosis ( valley fever ) patient receive anti-TNF biologic agent inflammatory arthritis Tucson , Arizona .</brief_summary>
	<brief_title>Risk Coccidioidomycosis Patients Receiving Anti-TNF Other Biologic Agents Inflammatory Arthritis</brief_title>
	<detailed_description>Retrospective chart review patient inflammatory arthritis see University Rheumatology clinic since January 2000 .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Coccidioidomycosis</mesh_term>
	<mesh_term>Coccidiosis</mesh_term>
	<criteria>All active patient inflammatory arthritis see University Arizona January 2000</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>TNF inhibitor</keyword>
	<keyword>Biologic agent</keyword>
	<keyword>coccidioidomycosis</keyword>
	<keyword>Rheumatoid arthritis</keyword>
</DOC>